IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples